MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE
https://doi.org/10.20996/1819-6446-2009-5-1-42-45
Abstract
Aim. To study the myocardial remodeling features in patients with stable angina depending on disease severity and experienced myocardial infarction (MI).
Material and methods. 148 male patients with stable angina were examined and randomized into 3 groups (G1-G3). 52 patients of G1 had angina of I-II functional class (FC). 49 patients of G2 had angina of III FC, and 47 patients of G3 had angina of IV FC. History of MI had 79,5, 87.2 and 92.6% of patients in G1, G2 and G3 respectively. 35 healthy men were included into control group. Coronarography, bicycle ergometry and 24-hour ECG monitoring was performed. Left ventricular (LV) function and remodeling was assessed with echocardiography.
Results. G3 patients had LV eccentric hypertrophy as a result of postinfarction cardiosclerosis which accompanied with LV systolic dysfunction, a myocardial stress increasing and LV spherification. G1 patients had no any significant disorders of LV systolic function.
Conclusion. Severe ischemic heart disease is associated with a dysadaptive remodeling unlike mild ischemic heart disease, which is associated with an adaptive myocardial remodeling.
About the Authors
A. N. ZakirovaRussian Federation
Lenina ul. 3, Ufa, 450000
R. G. Oganov
Russian Federation
Petroverigsky per. 10, Moscow, 101990
N. E. Zakirova
Russian Federation
Lenina ul. 3, Ufa, 450000
G. R. Klochkova
Russian Federation
Lenina ul. 3, Ufa, 450000
F. S. Musina
Russian Federation
Lenina ul. 3, Ufa, 450000
References
1. Оганов Р.Г., Масленникова Г.Я. Профилактика сердечно-сосудистых заболеваний – реальный путь улучшения демографической ситуации в России. Кардиология 2007;(1):4-7.
2. Беленков Ю.А. Ишемическая болезнь сердца как основная причина сердечной недостаточности. Журнал Сердечная недостаточность 2004;5(2):77-8.
3. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implication. Circulation 1990; 81(4):1161-72.
4. Мартынов А.И., Васюк Ю.А., Копелева М.В., Крикунов П.В. Постинфарктное ремоделирование левого желудочка: возможности β-адреноблокаторов. Кардиология 2001;(3):79-82.
5. Капелько В.И. Эволюция концепции и метаболическая основа ишемической дисфункции миокарда. Кардиология 2005;(9):55-61.
6. AСC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (AСC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography) Circulation 2003;108(9):1146-62.
7. Lang R., Biering M., Devereux R.B. et al. Recommendations of chambers quantification. Eur J Echocardiogr 2006;7(2):79-108.
8. Canau A., Devereux R.B., Roman M.J. et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992;19(7):1550-8.
9. Белов Ю.В., Вараксин В.А. Структурно-геометрические изменения миокарда и особенности центральной гемодинамики при постинфарктном ремоделировании левого желудочка. Кардиология 2003;(1):19-23.
10. Bolognese L., Cerisano G. Early predictors of left ventricular remodeling after myocardial infarction. Am Heart J 1999;138(2 Pt 2):S79-83.
11. Rahimtoola S.H. Hibernating myocardium has reduced blood flow at rest that increases with low-dose dobutamine. Circulation 1996;94(12):3055-61.
12. Smart S.C., Knickelbine T., Malik F., Sagar K.B. Dobutamine-atropine stress echocardiography for the detection of coronary artery disease in patients with left ventricular hypertrophy. Importance of chamber size and systolic wall stress. Circulation 2000;101(3):258-63.
13. Никитин Н.П., Аляви А.Л., Голоскокова В.Ю., Маджитов Х.Х. Особенности процесса позднего ремоделирования сердца у больных, перенесших инфаркт миокарда. Кардиология 1999;(1):54-8.
14. Batista R. Partial left ventriculectomy – the Batista procedure. Eur J Cardiothorac Surg 1999;15 Suppl 1:S12-9.
15. Kloner R.A., Arimie R.B., Kay G.L. et al. Evidence for stunned myocardium in humans: a 2001 update. Coron Artery Dis 2001;12(5):349-56.
16. Kloner R.A., Jennings R.B. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation 2001;104(24):2981-9.
17. Телкова И.Л., Тепляков А.Т. Взаимосвязи между изменениями коронарного кровотока, энергетическим метаболизмом миокарда и гиперинсулинемией у больных ишемической болезнью сердца. Кардиология 2005;(8):61-8.
18. Цыпленкова В.Г. Критические заметки по поводу парадигмы «гибернирующий и оглушенный миокард». Кардиология 2005;(9):43-6.
19. Ferrari R., Ceconi C., Curello S., Visioli O. The neuroendocrine and sympathetic nervous system in congestive heart failure. Eur Heart J 1998;19 Suppl F:F45-51.
20. Schelbert H.R. Measurement of myocardial metabolism in patents with ischemic heart disease. Am J Cardiol 1998;82(5A):61K-67K.
Review
For citations:
Zakirova A.N., Oganov R.G., Zakirova N.E., Klochkova G.R., Musina F.S. MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE. Rational Pharmacotherapy in Cardiology. 2009;5(1):42-45. (In Russ.) https://doi.org/10.20996/1819-6446-2009-5-1-42-45